These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 31658364)
1. Icariside II, a phosphodiesterase 5 inhibitor, attenuates cerebral ischaemia/reperfusion injury by inhibiting glycogen synthase kinase-3β-mediated activation of autophagy. Gao J; Long L; Xu F; Feng L; Liu Y; Shi J; Gong Q Br J Pharmacol; 2020 Mar; 177(6):1434-1452. PubMed ID: 31658364 [TBL] [Abstract][Full Text] [Related]
2. Icariside II, a novel phosphodiesterase 5 inhibitor, protects against H Gao J; Deng Y; Yin C; Liu Y; Zhang W; Shi J; Gong Q J Cell Mol Med; 2017 Feb; 21(2):375-386. PubMed ID: 27642051 [TBL] [Abstract][Full Text] [Related]
3. Icariside II attenuates cerebral ischemia/reperfusion-induced blood-brain barrier dysfunction in rats via regulating the balance of MMP9/TIMP1. Liu MB; Wang W; Gao JM; Li F; Shi JS; Gong QH Acta Pharmacol Sin; 2020 Dec; 41(12):1547-1556. PubMed ID: 32488170 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of GSK-3β alleviates cerebral ischemia/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy. Wang Y; Meng C; Zhang J; Wu J; Zhao J Int Immunopharmacol; 2019 Mar; 68():234-241. PubMed ID: 30703695 [TBL] [Abstract][Full Text] [Related]
5. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Collino M; Thiemermann C; Mastrocola R; Gallicchio M; Benetti E; Miglio G; Castiglia S; Danni O; Murch O; Dianzani C; Aragno M; Fantozzi R Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734 [TBL] [Abstract][Full Text] [Related]
6. Glycogen Synthase Kinase 3β Influences Injury Following Cerebral Ischemia/Reperfusion in Rats. Li Y; Zhu J; Liu Y; Chen X; Lei S; Li L; Jiang B; Tan L; Yu S; Zhao Y Int J Biol Sci; 2016; 12(5):518-31. PubMed ID: 27019634 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways. Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531 [TBL] [Abstract][Full Text] [Related]
8. The Akt/GSK-3β pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rats. Sun B; Chen L; Wei X; Xiang Y; Liu X; Zhang X Biochem Biophys Res Commun; 2011 Jun; 409(4):808-13. PubMed ID: 21624354 [TBL] [Abstract][Full Text] [Related]
9. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Zhu YM; Wang CC; Chen L; Qian LB; Ma LL; Yu J; Zhu MH; Wen CY; Yu LN; Yan M Brain Res; 2013 Feb; 1494():1-8. PubMed ID: 23219579 [TBL] [Abstract][Full Text] [Related]
10. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715 [TBL] [Abstract][Full Text] [Related]
11. Electroacupuncture attenuates cerebral ischemia-reperfusion injury in diabetic mice through adiponectin receptor 1-mediated phosphorylation of GSK-3β. Guo F; Jiang T; Song W; Wei H; Wang F; Liu L; Ma L; Yin H; Wang Q; Xiong L Mol Neurobiol; 2015 Apr; 51(2):685-95. PubMed ID: 24915968 [TBL] [Abstract][Full Text] [Related]
12. Apigenin-7- Wang J; Wang S; Sun S; Lu Y; Gao K; Guo C; Li R; Li W; Zhao X; Tang H; Wen A; Cai M; Zhang W Aging (Albany NY); 2020 Nov; 12(23):23872-23888. PubMed ID: 33263567 [TBL] [Abstract][Full Text] [Related]
13. GSK-3β downregulates Nrf2 in cultured cortical neurons and in a rat model of cerebral ischemia-reperfusion. Chen X; Liu Y; Zhu J; Lei S; Dong Y; Li L; Jiang B; Tan L; Wu J; Yu S; Zhao Y Sci Rep; 2016 Feb; 6():20196. PubMed ID: 26838164 [TBL] [Abstract][Full Text] [Related]
14. MiR-202-5p attenuates neurological deficits and neuronal injury in MCAO model rats and OGD-induced injury in Neuro-2a cells by targeting eIF4E-mediated induction of autophagy and inhibition of Akt/GSK-3β pathway. Li B; Huang Z; Meng J; Yu W; Yang H Mol Cell Probes; 2020 Jun; 51():101497. PubMed ID: 31877332 [TBL] [Abstract][Full Text] [Related]
15. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Collino M; Aragno M; Castiglia S; Tomasinelli C; Thiemermann C; Boccuzzi G; Fantozzi R Diabetes; 2009 Jan; 58(1):235-42. PubMed ID: 18840784 [TBL] [Abstract][Full Text] [Related]
16. Icariside II, a PDE5 Inhibitor, Suppresses Oxygen-Glucose Deprivation/Reperfusion-Induced Primary Hippocampal Neuronal Death Through Activating the PKG/CREB/BDNF/TrkB Signaling Pathway. Xu F; Lv C; Deng Y; Liu Y; Gong Q; Shi J; Gao J Front Pharmacol; 2020; 11():523. PubMed ID: 32390851 [TBL] [Abstract][Full Text] [Related]
17. Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway. Majd S; Power JH; Koblar SA; Grantham HJ Eur J Neurosci; 2016 Aug; 44(3):1987-97. PubMed ID: 27177932 [TBL] [Abstract][Full Text] [Related]
18. A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway. Pang T; Wang YJ; Gao YX; Xu Y; Li Q; Zhou YB; Xu L; Huang ZJ; Liao H; Zhang LY; Gao JR; Ye Q; Li J Acta Pharmacol Sin; 2016 Jun; 37(6):741-52. PubMed ID: 27108601 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotection induced by sevoflurane-delayed post-conditioning is attributable to increased phosphorylation of mitochondrial GSK-3β through the PI3K/Akt survival pathway. Ye Z; Xia P; Cheng ZG; Guo Q J Neurol Sci; 2015 Jan; 348(1-2):216-25. PubMed ID: 25555490 [TBL] [Abstract][Full Text] [Related]
20. FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3β/ β-catenin signaling pathway. Xu B; Wang T; Xiao J; Dong W; Wen HZ; Wang X; Qin Y; Cai N; Zhou Z; Xu J; Wang H Biochem Pharmacol; 2019 May; 163():234-249. PubMed ID: 30797872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]